ArticleTherapeutic advances in drug safety2026
Post-marketing safety signals and report-level ARIA-E stratification for lecanemab and donanemab: an integrated FAERS and WHO-VigiAccess pharmacovigilance study.
Wei-Yang Xue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.